173 results
8-K
EX-4.3
BPTH
Bio-Path Holdings Inc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes … , as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees
8-K
EX-4.2
BPTH
Bio-Path Holdings Inc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses … thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required
8-K
EX-4.4
BPTH
Bio-Path Holdings Inc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance … by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
Subsidiary is in default with respect to any Indebtedness.
(bb) Tax Status. Except for matters that would not, individually or in the aggregate, have … , state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject
8-K
EX-4.1
BPTH
Bio-Path Holdings Inc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect … duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
8-K
EX-10.2
46628p i706w0hc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
424B5
l6x2jbn87496s6z
19 Apr 24
Prospectus supplement for primary offering
3:28pm
8-K
EX-4.2
8xntpwzfh sprowui
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
8-K
EX-10.1
g9aoswyt4yk01cbsj6
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
8-K
EX-4.1
qy3n z6eoqsw7oze
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
424B5
md3bxuo3
19 Apr 24
Prospectus supplement for primary offering
9:17am
8-K
EX-10.1
nhyjkkoxy5 eyd
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
424B5
hpfl5pt288kpn3pb
4 Apr 24
Prospectus supplement for primary offering
4:33pm
424B5
zkpqi4kh cl
27 Mar 24
Prospectus supplement for primary offering
8:15am
8-K
EX-10.1
zc7 wrlflpfoun8et2p
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
8-K
EX-4.1
4sppc05
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
8-K
EX-4.2
180maj wj
26 Mar 24
Entry into a Material Definitive Agreement
8:03am